missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human Complement Component C5aR1 Antibody, R&D Systems™

Mouse Monoclonal Antibody has been used in 2 publications
Brand: R&D Systems MAB3648
This item is not returnable.
View return policy
Description
Complement Component C5aR1 Monoclonal specifically detects Complement Component C5aR1 in Human samples. It is validated for Flow Cytometry, Neutralization, CyTOF-ready.
Specifications
| Complement Component C5aR1 | |
| Monoclonal | |
| LYOPH | |
| Flow Cytometry 2.5 ug/10^6 cells, Neutralization 2-10 ug/mL, CyTOF-ready | |
| P21730 | |
| C5AR1 | |
| NS0 mouse myeloma cell line transfected with human Complement Component C5a R1 Met1-Val350 Accession # P21730 | |
| 100 μg | |
| Primary | |
| Detects human Complement Component C5a R1. Stains human Complement Component C5a R1 transfected cells but not irrelevant transfectants. | |
| Human | |
| Purified |
| Flow Cytometry, Neutralization, CyTOF | |
| 347214 | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| C5A, C5a anaphylatoxin chemotactic receptor, C5aR, C5a-R, C5AR1, C5ARC5a anaphylatoxin receptor, C5R1C5a ligand, CD88, CD88 antigen, complement component 5 receptor 1, complement component 5 receptor 1 (C5a ligand), complement component 5a receptor 1, Complement Component C5a R1 | |
| Mouse | |
| Protein A or G purified from hybridoma culture supernatant | |
| RUO | |
| 728 | |
| Reconstitute at 0.5 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
| IgG2a |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction